Spending power
TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.
Spending power
Key facts
Counted staff
101
self-reported 11–50 band
Founded
1998
28 years
Registry matches
3
ABR
Office countries
1
1 address
Funding rounds
3
Post IPO equity · Jan 2021 · US$ 7.8M
Company type
Public Company
self-reported
Legal entities
1 brand → 3 possible registrationsThe join is a normalised name comparison against ABR. Treat every row below as a lead to verify, not as an established identity.
ACRUX HOLDINGS PTY. LIMITED
ABN77009599491
ACRUX LIMITED
ABN72082001152
ACRUX HOLDINGS PTY. LTD.
ABN89626944296
Legal entities
Show as table · Acrux: 3 registry entities
| ACRUX HOLDINGS PTY. LIMITED | ABN 77009599491 |
|---|---|
| ACRUX LIMITED | ABN 72082001152 |
| ACRUX HOLDINGS PTY. LTD. | ABN 89626944296 |
| Confirmed matches | 0 of 3 |
A candidate is a name match on the registry, not a confirmed identity, and two candidates are ambiguity rather than a corporate structure.
Description
Acrux is a specialty pharma company with a successful track record of developing and commercialising a pipeline of topically applied pharmaceutical products. Drawing on 25 years of experience, Acrux has successfully marketed through licensees a number of products worldwide with emphasis on the United States. Acrux is formulating and developing a range of topical generic products by leveraging its highly skilled workforce, on-site laboratories, GMP manufacturing suite, technical, clinical and commercial experience to bring affordable products to market. Acrux encourages collaboration and is well positioned to discuss commercial partnering and product development opportunities.
Locations
Country footprint
Show as table · Offices in 1 country
| Countries | 1 |
|---|---|
| Primary country | AU |
All codes: AU
Addresses
- AU103-113 Stanley St; Melbourne, VIC 3003Primary
Grid intelligence Members
Funding
Last round · 21 January 2021US$ 7.8MPost IPO equity
Rounds3
Round typePost IPO equity · secondary transaction
Amount (USD)7,800,000
Stage rank6
Investors named0
Since last round5 yr
Funding
Show as table · 3 funding rounds
| Rounds | 3 |
|---|---|
| Axis | 1998 to 2026 |
| Post IPO equity · 21 Jan 2021 | US$ 7.8M |
Dated rounds only. The axis ends at the date this profile was last observed, not at today.
Signals & hiring
Hiring, headcount and registry-change signals, streamed to members.
Latest signal
Hiring activity
Headcount trend
Financials
Registry-filed capital and financial indicators, standardised by TheGrid.
Paid-up capital
Fiscal period
Registered charges
Revenue
Profit / loss
People & contacts
4 employee profiles on record · names withheld.
Names and titles are intentionally absent from this page. The source relation carries no consent record across the privacy regimes this directory spans, so it is never requested and never stored. Search engines see exactly what you see here.
The people relation is never requested, so there is nothing here to unlock.
FAQ
Which legal entities operate under Acrux?
Three Australian entities on the ABR: ACRUX HOLDINGS PTY. LIMITED (ABN 77 009 599 491), ACRUX LIMITED (ABN 72 082 001 152) and ACRUX HOLDINGS PTY. LTD. (ABN 89 626 944 296). All medium confidence.
How many people work at Acrux?
101 counted staff profiles at January 2026, above the self-reported 11–50 band.
Where does Acrux have offices?
One address on record, Australia only. Primary: 103-113 Stanley St, Melbourne, VIC 3003.
Has Acrux raised funding?
Three rounds. Latest 21 January 2021: post IPO equity, US$7,800,000.
Which companies are listed alongside Acrux?
6 profiles list Acrux as a peer — 75th percentile in Pharmaceutical Manufacturing. It lists ten peers of its own.